DaShenLin Pharmaceutical Group Co Ltd
603233
Company Profile
Business description
DaShenLin Pharmaceutical Group Co Ltd is engaged in the pharmaceutical manufacturing, retail, and wholesale business. The company is based on the development of the pharmacy chain. It primarily offers Chinese herbal medicine such as antibiotics and biochemical drugs. The business activities are geographically carried out through China.
Contact
No. 410-1, Longxi Avenue
Liwan District
Guangdong Province
Guangzhou510000
CHNT: +86 2081689688
Sector
Healthcare
Stock type
Defensive
Industry
Pharmaceutical Retailers
Fiscal Year End
31 December 2026
Employees
41,141
Stocks News & Analysis
stocks
Investors overlooking ASX share’s potential
International expansion is a distraction from valuable local business.
stocks
Cerebras sees blockbuster demand, setting stage for US AI IPO frenzy
The chipmaker’s IPO priced at $185, well above its initial range, and opened trading at an eye-popping $350.
stocks
What did Morningstar subscribers buy and sell in April?
How the most traded shares in April stack up against our analysts views.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,922.60 | 5.30 | 0.06% |
| CAC 40 | 8,082.27 | 0.00 | 0.00% |
| DAX 40 | 24,456.26 | 319.45 | 1.32% |
| Dow JONES (US) | 50,063.46 | 370.26 | 0.75% |
| FTSE 100 | 10,372.93 | 47.58 | 0.46% |
| HKSE | 26,389.04 | 0.60 | 0.00% |
| NASDAQ | 26,635.22 | 232.88 | 0.88% |
| Nikkei 225 | 62,596.24 | 57.81 | -0.09% |
| NZX 50 Index | 12,995.72 | 29.35 | -0.23% |
| S&P 500 | 7,501.24 | 56.99 | 0.77% |
| S&P/ASX 200 | 8,681.10 | 7.60 | 0.09% |
| SSE Composite Index | 4,177.92 | 64.65 | -1.52% |